Invitation to a press conference on Bittium Corporation’s Financial Statement 2017
Press Release
Free for publication on February 15, 2018 at 12pm (CET+1)
Invitation to a press conference on Bittium Corporation’s Financial Statement 2017
Bittium Corporation’s Financial Statement Bulletin 2017 will be published on Thursday, February 22, 2018, at 8.00am (CET+1). The release will be available on company’s website www.bittium.com immediately after the publication.
Bittium will hold a press conference for media, analysts and institutional investors on February 22, 2018, at 9.30am (CET+1) in Restaurant Savoy, Eteläesplanadi 14, Helsinki. The conference will be held in Finnish.
Bittium will also hold a telephone conference for media, analysts and institutional investors on the same day at 11.00am (CET+1). Dial-in number for the conference call is + 44 20 3059 8125, confirmation code is “Bittium”. The conference can be followed also as an audiocast, accessible at www.bittium.com/investors. The conference call will be held in English.
Instructions on how to participate will be available at www.bittium.com/investors soon.
A recording of the audiocast and the presentation will be available after the conference on Bittium’s website at www.bittium.com/investors.
Further information:
Karoliina Fyrstén
Director, Corporate Communications and Marketing
Tel. +358 40 344 2789
Distribution:
Main media
www.bittium.com/investors
Bittium
Bittium specializes in the development of reliable, secure communications and connectivity solutions leveraging its 30 year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. Complementing its communications and connectivity solutions, Bittium offers proven information security solutions for mobile devices and portable computers. From November 2016 onwards, Bittium offers its customers also healthcare technology products and services in biosignal measuring in the areas of cardiology, neurology, rehabilitation, occupational health and sports medicine. Net sales in 2016 was EUR 64.2 million and operating profit was EUR 2.5 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com.